US appeals court revives private lawsuits linking Tylenol to autism, ADHD

A US appeals court has revived private lawsuits that claim a link between Tylenol and the development of autism and ADHD. Following this judicial decision, Kenvue stock experienced a decline. The court's action allows these legal challenges to proceed, focusing on the alleged connection between the medication and these neurodevelopmental disorders. This development has directly impacted the market performance of Kenvue as the company faces the potential of renewed litigation regarding its product safety.